您所在的位置: 首页 --> 导师团队 --> 何忠虎

导师基本信息

  • 姓名:何忠虎
  • 性别:
  • 民族:汉族
  • 科室:遗传学研究室
  • 职称:研究员,副教授
  • 专业:流行病与卫生统计学
  • E-MAIL: zhonghuhe@foxmail.com

学术论文 | 综述述评 | 出版专著 | 研究方向 | 科研项目 | 招生计划

Z. He#, Z. Liu#, M. Liu#, C. Guo, R. Xu, F. Li, A. Liu, H. Yang, L. Shen, Q. Wu, L. Duan, X. Li, C. Zhang, Y. Pan, H. Cai, and Y. Ke, Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial.,GUT,68(2):198-206

M. Liu#, Z. Liu#, F. Liu#, C. Guo, R. Xu, F. Li, A. Liu, H. Yang, S. Zhang, L. Shen, L. Duan, Q. Wu, C. Cao, Y. Pan, Y. Liu, J. Li, H. Cai, Z. He* and Y. Ke*. Absence of Iodine Staining Associates With Progression of Esophageal Lesions in a Prospective Endoscopic Surveillance Study in China.,Clin Gastroenterol Hepatol,18(7): 1626-1635.

Liu F#, Liu M#, Liu Y#, Guo C, Zhou Y, Li F, Xu R, Liu Z, Deng Q, Li X, Zhang C, Pan Y, Ning T, Dong X, Hu Z, Bao H, Cai H, Silva IDS*, He Z*, and Ke Y*,Chin J Cancer Res,32(6): 742-754

Z. He and Y. Ke, Precision screening for esophageal squamous cell carcinoma in China.,Chin J Cancer Res,32(6):673-682

Z. Liu#, C. Guo#, Y. He#, Y. Chen#, P. Ji#, Z. Fang#, F. Li, Y. Tang, X. Chen, P. Xiao, C. Wang, W. Yin, H. Guo, M. Liu, Y. Pan, F. Liu, Y. Liu, Z. He*, and Y. Ke*, A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China.,Gastrointest Endosc,91(6):1253-1260.

M. Wang#, M. Liu#, F. Li, C. Guo, Z. Liu, Y. Pan, Y. Liu, F. Liu, H. Cai, Y. Wu, Z. He*, and Y. Ke*, Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese.,Lipids Health Dis,19(1): 135.

H. Tian#, W. Yang#, Y. Hu#, Z. Liu#, L. Chen, L. Lei, F. Zhang, F. Cai, H. Xu, M. Liu, C. Guo, Y. Chen, P. Xiao, J. Chen, P. Ji, Z. Fang, F. Liu, Y. Liu, Y. Pan, I. Dos-Santos-Silva, Z. He*, and Y. Ke*, Estimating cancer incidence based on claims data from medical insurance systems in two areas lacking cancer registries in China.,EClinicalMedicine,20: 100312.

H. Tian, R. Xu, F. Li, C. Guo, L. Zhang, Z. Liu, M. Liu, Y. Pan, Z. He*, Y. Ke.Identification of cancer patients using claims data from health insurance systems: A real-world comparative study.,Chin J Cancer Res,31(4): 699-706.

F. Li#., X. Li#, C. Guo, R. Xu, F. Li, Y. Pan, M. Liu, Z. Liu, C. Shi, H. Wang, M. Wang, H. Tian, F. Liu, Y. Liu, J. Li, H. Cai, L. Yang, Z. He* and Y. Ke*.Estimation of cost for endoscopic screening for esophageal cancer in a high-risk population in rural China: results from a population-level randomized controlled trial.,Pharmacoeconomics,37(6): 819-827

C. Shi#, M. Liu#, Z. Liu, C. Guo, F. Li, R. Xu, F. Liu, Y. Liu, J. Li, H. Cai, Z. He* and Y. Ke* . Using Health Insurance Reimbursement Data to Identify Incident Cancer Cases.,J Clin Epidemiol,114:141-149.

M.Liu#, Z. He#, C. Guo, R. Xu, F. Li, T. Ning, Y. Pan, Y. Li, H. Ding, L. Zheng, Y. Zhou, X. Tian, W. Yang, X. Wang, F. Lu, Y. Zhang, Y. Zhao, F. Guo, K. Chen, L. Gao, M. Sun, Y. Liu, F. Liu, D. Hang, N. Shen, J. Li, Z. Xu, Q. Wang, C. Zhang, A. Abliz, Q. Deng, X. Li, Z. Liu, C. Zhang, W. Yuan, H. Wang, N. S. Weiss#, H. Cai# and Y. Ke#. Effectiveness of Intensive Endoscopic Screening for Esophageal Cancer in China: A Community-Based Study.,Am J Epidemiol,188(4): 776-784.

H. Wang#, Y. Pan#, C. Guo, F. Li, R. Xu, M. Liu, Z. Liu, F. Liu, H. Cai, Y. Ke*, and Z. He*, Health-related quality of life among rural residents aged 45-69 years in Hua County, Henan Province, China: Results of ESECC Trial for esophageal cancer screening with endoscopy.,Chin J Cancer Res,30(2):240-253

M. Liu#., F. Liu#, Y. Pan#, Z. He#, C. Guo, C. Zhang, X. Li, D. Hang, Q. Wang, Y. Liu, J. Li, Z. Liu, H. Cai, and Y. Ke, Viral Load in the Natural History of Human Papillomavirus Infection Among Men in Rural China: A Population-based Prospective Study.,Clinical Infectious Diseases,67(12): 1861-1867.

J. Li#, R. Xu#, M. Liu#, H. Cai, C. Cao, F. Liu, F. Li, C. Guo, Y. Pan, Z. He*, and Y. Ke*, Lugol Chromoendoscopy Detects Esophageal Dysplasia With Low Levels of Sensitivity in a High-Risk Region of China.,Clin Gastroenterol Hepatol,16(10):1585-1592.

T. Lin#, T. Liu#, Y. Lin, C. Zhang, L. Yan, Z. Chen, Z. He*, and J. Wang*, Serum levels of chemical elements in esophageal squamous cell carcinoma in Anyang, China: a case-control study based on machine learning methods.,BMJ Open,2017;7(9):e015443

Liu M#, Zhou R#, Liu Z#, Guo C, Xu R, Zhou F, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Zheng H, Tian H, Liu F, Liu Y, Pan Y, Chen H, Hu Z, Cai H, He Z*, and Ke Y*. Update and validation of a diagnostic model to identify prevalent malignant lesions in esophagus in general population.,EClinicalMedicine,47:101394.

Li F, Hu Y, Guo C, Lei L, Li F, Liu M, Liu Z, Pan Y, Liu F, Liu Y, Hu Z, Chen H, He Z*, and Ke Y*. Economic Burden Conferred by Population-Level Cancer Screening on Resource-Limited Communities: Lessons from the ESECC Trial.,Front Oncol,12:849368

Zhou R#, Zheng H#, Liu M#, Liu Z#, Guo C, Tian H, Liu F, Liu Y, Pan Y, Chen H, Hu Z, Cai H, He Z*, and Ke Y*. Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations.,Chin J Cancer Res,33(6):649-658.

Wang M#, Liu M#, Guo C, Li F, Liu Z, Pan Y, Liu F, Liu Y, Bao H, Hu Z, Cai H, He Z*, and Ke Y*. Association of early-life undernutrition and risk of dyslipidemia in adulthood: a population-based cohort study.,BMC Public Health,21(1): 2129.

Wang M#, Liu F#, Pan Y#, Xu R, Li F, Liu A, Yang H, Duan L, Shen L, Wu Q, Liu Y, Liu M, Liu Z, Hu Z, Chen H, Cai H, He Z*, and Ke Y*. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?,EBioMedicine,73: 103674.

Liu M#, Zhou R#, Guo C, Xu R, Liu A, Yang H, Li F, Duan L, Shen L, Wu Q, Liu Z, Liu F, Liu Y, Pan Y, Cai H, Weiss NS*, He Z* and Ke Y*. Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.,Gastrointest Endosc,93(5):1065-1073.

Precision screening for esophageal squamous cell carcinoma in China,Chinese Journal of Cancer Research,32(6):673-682

精准健康管理, 参编, 北京大学医学出版社, 2020.10

胃癌高低发区影响因素的综合调查, 子课题负责人, 2020.1.1~2022.12.31, 国家科技部

基于前瞻性队列的食管癌早期预警生物标志物筛选及风险预测研究, 2020.11.1~2023.10.31, 北京市自然科学基金京津冀基础研究合作专项

食管癌专病队列研究—高发现场食管癌及其癌前病变人群前瞻性队列研究, 子课题负责人, 2016.7.1~2020.12.31, 国家重点研发计划“精准医学研究 (2016YFC0901404)

基于前瞻性队列的食管癌早期预警生物标志物筛选及风险预测研究, 课题负责人, 2021.1.1~2022.12.31, 北京市百千万人才工程

基于前瞻性人群队列的食管癌早期预警生物标志物筛选及风险预测研究, 课题负责人, 2021.1.1~2024.12.31, 国家自然科学基金面上项目

流行病学—北京市卫生系统高层次卫生技术人才培养计划, 课题负责人, 2014.12.1~2017.12.31, 北京市卫生系统高层次卫生技术人才队伍建设工程 2014-3-066

中国人群HPV感染自然史及传播风险的前瞻性队列研究, 课题负责人, 2015.1.1~2018.12.31, 国家自然科学及基金面上项目(81473033)

基于前瞻性人群队列的食管癌早期预警生物标志物筛选及风险预测研究, 课题负责人, 2021.1.1~2024.12.31, 国家自然基金面上项目

常见恶性肿瘤联合早筛模式的建立及卫生经济学评价, 子课题负责人, 2021.12.1~2024.11.30, 国家重点研发计划

研究生招生计划
招生年度 招生专业 学位级别 学位类型 研究方向 选拔方式
2023 流行病与卫生统计学 博士 科学学位 上消化道恶性肿瘤精准防治、医学大数据挖掘与应用(含医学创新交叉项目1) 申请考核制
2023 流行病与卫生统计学 硕士 科学学位 上消化道恶性肿瘤精准防治、医学大数据挖掘与应用 全国统考

社会任职

  • 常委
  • 副主任委员
  • 委员
  • 委员
  • 委员

学习、工作经历

  • 2019.8.1~,北京大学肿瘤医院 研究员、博士生导师
  • 2016.8.1~,遗传室副主任、基础教研室副主任
  • 2011.5.2~2019.7.31,北京大学肿瘤医院 副研究员 硕士生导师
  • 2010.9.2~2011.8.2,美国华盛顿大学(UW)流行病学系 访问学者
  • 2008.8.2~2011.5.2,北京大学临床肿瘤学院 助理研究员